Core Viewpoint - Yonghe Intelligent Control is undergoing a significant change in control, with its actual controller planning to exit after six years, raising concerns about the company's future direction and performance [2][6][9] Group 1: Ownership Change - On August 6, Yonghe Intelligent Control announced that its controlling shareholder, Cao Delin, signed a share transfer agreement with Hangzhou Runfeng, intending to sell 8% of his shares for 320 million yuan [2][4] - The share transfer price of 8.97 yuan per share represents a 37% premium over the previous trading day's closing price of 6.55 yuan [4] - Following the announcement, the company's stock price initially surged but then fell by over 9% on the day of the announcement, closing down 5.8% [2][4] Group 2: New Shareholder's Background - Hangzhou Runfeng was established less than a month before the share transfer and has a registered capital of 20 million yuan, with a business scope that includes industrial robot manufacturing [5][6] - Despite its registration, Yonghe Intelligent Control stated that Hangzhou Runfeng would not engage in robot-related businesses and would change its business scope within ten working days [5][6] Group 3: Historical Context and Performance - Yonghe Intelligent Control has a history of multiple ownership changes and attempts to diversify into the medical and photovoltaic sectors, but these efforts have not yielded positive results [6][9] - The company's revenue from medical services and other businesses accounted for only 14.39% of total revenue as of 2024, with several hospitals still operating at a loss [6][9] - The company has faced declining profits, with net losses of 26.7 million yuan, 156 million yuan, and 297 million yuan from 2022 to 2024, and it is projected to incur further losses in the first half of this year [9]